VEGFA and neoplasm: A possible key role for TSP-1 in mediating some of the metronomic antiangiogenic effects of CPT-11 in vivo was suggested by the enhancement of the gene expression of the endogenous inhibitor in tumour xenografts found only in the low-dose-treated mice, whereas the VEGF immunohistochemistry analysis revealed no significant changes.